These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 19609471

  • 1. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
    Diamantis ML, Bartlett BL, Tyring SK.
    Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of imiquimod in anogenital warts from HIV-positive men.
    Herrera S, Correa LA, Wolff JC, Gaviria A, Tyring SK, Sanclemente G.
    J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
    [Abstract] [Full Text] [Related]

  • 4. Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males.
    Maw RD, Kinghorn GR, Bowman CA, Goh BT, Nayagam AT, Nathan M.
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):58-62. PubMed ID: 11952292
    [Abstract] [Full Text] [Related]

  • 5. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
    Beutner KR, Tyring SK, Trofatter KF, Douglas JM, Spruance S, Owens ML, Fox TL, Hougham AJ, Schmitt KA.
    Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
    [Abstract] [Full Text] [Related]

  • 6. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
    Fife KH, Ferenczy A, Douglas JM, Brown DR, Smith M, Owens ML, HPV Study Group.
    Sex Transm Dis; 2001 Apr; 28(4):226-31. PubMed ID: 11318254
    [Abstract] [Full Text] [Related]

  • 7. [Mechanisms of imiquimod indirect antiviral activity].
    Hober D, Ajram L, Chehadeh W, Lazrek M, Goffard A, Dewilde A, Wattré P.
    Ann Biol Clin (Paris); 2005 Apr; 63(2):155-63. PubMed ID: 15771973
    [Abstract] [Full Text] [Related]

  • 8. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
    Syed TA, Hadi SM, Qureshi ZA, Ali SM, Kwah MS.
    J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
    Schöfer H.
    Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
    [Abstract] [Full Text] [Related]

  • 10. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonne JP, Dupin N, Mougin C.
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [Abstract] [Full Text] [Related]

  • 11. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
    Carrasco D, vander Straten M, Tyring SK.
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
    [Abstract] [Full Text] [Related]

  • 12. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
    Gayed SL.
    Int J STD AIDS; 2002 May; 13(5):349-51. PubMed ID: 11972940
    [Abstract] [Full Text] [Related]

  • 13. Topical imiquimod: a review of its use in genital warts.
    Perry CM, Lamb HM.
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.
    Gollnick H, Barasso R, Jappe U, Ward K, Eul A, Carey-Yard M, Milde K.
    Int J STD AIDS; 2001 Jan; 12(1):22-8. PubMed ID: 11177478
    [Abstract] [Full Text] [Related]

  • 15. Imiquimod in clinical practice.
    Edwards L.
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
    [Abstract] [Full Text] [Related]

  • 16. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
    Garland SM, Waddell R, Mindel A, Denham IM, McCloskey JC.
    Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
    [Abstract] [Full Text] [Related]

  • 17. Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases.
    Rosenblatt A, de Campos Guidi HG.
    Int J STD AIDS; 2012 Dec; 23(12):909-10. PubMed ID: 23258837
    [Abstract] [Full Text] [Related]

  • 18. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
    Hoyme UB, Hagedorn M, Schindler AE, Schneede P, Hopfenmüller W, Schorn K, Eul A.
    Infect Dis Obstet Gynecol; 2002 Dec; 10(2):79-88. PubMed ID: 12530484
    [Abstract] [Full Text] [Related]

  • 19. Topical Imiquimod 5% cream therapy for external anogenital warts in pregnant women: report of four cases and review of the literature.
    Ciavattini A, Tsiroglou D, Vichi M, Di Giuseppe J, Cecchi S, Tranquilli AL.
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):873-6. PubMed ID: 21815878
    [Abstract] [Full Text] [Related]

  • 20. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
    Syed TA, Ahmadpour OA, Ahmad SA, Ahmad SH.
    J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.